Augmentin and Cabg - a phase IV clinical study of FDA data
Summary:
We study 42,826 people who take Augmentin (amoxicillin; clavulanate potassium) or have Cabg. No report of Cabg is found in people who take Augmentin.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Augmentin?
Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.
What is Cabg?
Cabg: no further information found. Check the latest studies of Cabg.
No report is found.
Do you take Augmentin and have Cabg?
- Check whether Cabg is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Augmentin:
- Augmentin (42,620 reports)
Cabg treatments and more:
- Cabg (206 reports)
How severe was Cabg and when was it recovered:
Expand to all the drugs that have ingredients of amoxicillin; clavulanate potassium:
Browse all side effects of Augmentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cabg:
Browse all the conditions that are associated with Cabg:
How the study uses the data?
The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium (the active ingredients of Augmentin) and Augmentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Urethral Pain and drugs of ingredients of ranitidine - a second ago
- Intervertebral Disc Degeneration and drugs of ingredients of ocrelizumab - a second ago
- Drug interactions of Aleve and Kineret - 7 seconds ago
- Tylenol and Palmar-Plantar Erythrodysaesthesia Syndrome for Men aged 50-59 - 8 seconds ago
- Faslodex and Rashes for Women aged 40-49 - 9 seconds ago
- Faslodex and Rash Generalised for Women aged 40-49 - 9 seconds ago
- Faslodex and Rash for Women aged 40-49 - 9 seconds ago
- Faslodex and Skin Rash for Women aged 40-49 - 10 seconds ago
- Faslodex and Skin Lesion for Women aged 40-49 - 10 seconds ago
- Faslodex and Rubor for Women aged 40-49 - 10 seconds ago